These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 22237887)

  • 1. Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.
    Hurwitz AA; Watkins SK
    Cancer Immunol Immunother; 2012 Feb; 61(2):289-293. PubMed ID: 22237887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.
    DeVito NC; Plebanek MP; Theivanthiran B; Hanks BA
    Front Immunol; 2019; 10():2876. PubMed ID: 31921140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
    Fu C; Jiang A
    Front Immunol; 2018; 9():3059. PubMed ID: 30619378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL21 Programs Immune Activity in Tumor Microenvironment.
    Sharma S; Kadam P; Dubinett S
    Adv Exp Med Biol; 2020; 1231():67-78. PubMed ID: 32060847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC.
    Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S
    Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell death and cancer immune tolerance.
    Lu B; Finn OJ
    Cell Death Differ; 2008 Jan; 15(1):70-9. PubMed ID: 18007660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing dendritic cells in cancer.
    Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
    Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells.
    Badillo O; Helfridsson L; Niemi J; Hellström M
    Ups J Med Sci; 2024; 129():. PubMed ID: 38716077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tumor immunity by tumor/dendritic cell fusions.
    Koido S; Homma S; Hara E; Namiki Y; Takahara A; Komita H; Nagasaki E; Ito M; Ohkusa T; Gong J; Tajiri H
    Clin Dev Immunol; 2010; 2010():516768. PubMed ID: 21048993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
    Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
    Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling defects in anti-tumor T cells.
    Frey AB; Monu N
    Immunol Rev; 2008 Apr; 222():192-205. PubMed ID: 18364003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
    Yan W; Jiang S
    Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.
    Rausch MP; Sertil AR
    Int Rev Immunol; 2015 Mar; 34(2):104-22. PubMed ID: 25774773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor immunity: myeloid leukocytes control the immune landscape.
    Rutkowski MR; Stephen TL; Conejo-Garcia JR
    Cell Immunol; 2012; 278(1-2):21-6. PubMed ID: 23121972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.
    Verneau J; Sautés-Fridman C; Sun CM
    Semin Immunol; 2020 Apr; 48():101410. PubMed ID: 33011065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.
    Zheng R; Kjaergaard J; Lee WT; Cohen PA; Shu S
    Cancer Treat Res; 2007; 135():223-37. PubMed ID: 17953420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.